[Detection and management of lipid disorders in the diabetic patient].
Diabetics patients have a greater risk of morbi-mortality associated to macrovascular disease, which may show as ischemic cardiopathy, stroke and peripheric vascular disease. The high atherogenesis in these patients. Consequently, the therapeutical goals aimed to the reduction of plasmatic lipids must be stricter among the diabetic population and, especially, among women, that among non-diabetic subjects. The first therapeutical step should be to reach a proper metabolic control through diet, exercise and, if necessary, insulin or oral antidiabetics. If these measures are not enough, hypolipemic drugs should be added.
Laudo Pardos
C
C
Dpto. de Farmacología, Colegio Universitario de Soria.
Puigddevall Gallego
V
V
San Martín Barrio
L
L
D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000378:metabolism; D004041:Dietary Fats / Q000008:administration & dosage; D015444:Exercise; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008055:Lipids / Q000097:blood; D008297:Male; D015995:Prevalence; D012307:Risk Factors
D004041:Dietary Fats; D000960:Hypolipidemic Agents; D008055:Lipids
Detección y manejo de los trastornos lipídicos en el paciente diabético.